Bristol-Myers Squibb | BMY

Stock Price
62.80
Daily Change
0.66 1.06%
Monthly
9.07%
Yearly
28.90%
Q4 Forecast
60.81

EPS Reference Time Actual Consensus Previous
2026-10-29 FY2026Q3 AM 1.35 1.60 1.63
2026-07-30 FY2026Q2 AM 2.04 1.61 1.46
2026-04-30 FY2026Q1 AM 1.58 1.45 1.80
2026-02-05 FY2025Q4 AM 1.26 1.61 1.67
2025-10-30 FY2025Q3 AM 1.63 1.69 1.80



Peers Price Chg Day Year Date
AbbVie 293.89 0.59 0.20% 30.52% Nov/10
Abbott 110.46 -0.05 -0.05% -13.02% Nov/10
ALKERMES 46.47 0.30 0.65% 37.44% Nov/10
Amgen 465.23 0 0% 37.46% Nov/10
AstraZeneca 13,911.00 27.00 0.19% 2.91% Nov/11
Biogen 253.25 -1.62 -0.64% 58.72% Nov/10
Bristol-Myers Squibb 62.80 0.66 1.06% 28.90% Nov/10
Coherus Biosciences 0.64 -0.18 -21.65% -52.53% Nov/10
Gilead Sciences 170.87 1.55 0.92% 39.42% Nov/10
GlaxoSmithKline 1,915.50 -1.50 -0.08% 5.05% Nov/11

Indexes Price Day Year Date
US Index 500 7580 -29.00 -0.38% 10.64% Nov/11

Bristol-Myers Squibb traded at $62.80 this Tuesday November 10th, increasing $0.66 or 1.06 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb gained 9.07 percent. Over the last 12 months, its price rose by 28.90 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 60.81 by the end of this quarter and at 56.99 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.



News Stream
Bristol-Myers Squibb Shares Hit 4-week High
Bristol-Myers Squibb shares increased to 63.61 USD, the highest since September 2026. Over the past 4 weeks, Bristol-Myers Squibb gained 1.51%, and in the last 12 months, it increased 38.84%.
2026-10-30
Bristol-Myers Squibb Shares Hit 10-week Low
Bristol-Myers Squibb shares decreased to 60.48 USD, the lowest since July 2026. Over the past 4 weeks, Bristol-Myers Squibb lost 9.16%, and in the last 12 months, it increased 34.4%.
2026-10-02
Bristol-Myers Squibb Stock Price Hits 4-week Low
Bristol-Myers Squibb shares decreased to 63.35 USD, the lowest since August 2026. Over the past 4 weeks, Bristol-Myers Squibb lost 0.41%, and in the last 12 months, it increased 37.32%.
2026-09-11